Two Sigma Advisers’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,660
Closed -$2.18M 931
2025
Q4
$2.18M Buy
+4,660
New +$2.16M ﹤0.01% 1154
2025
Q1
Sell
-67,600
Closed -$20.3M 2464
2024
Q4
$20.3M Buy
+67,600
New +$23.6M 0.05% 308
2024
Q3
Sell
-1,200
Closed -$386K 2375
2024
Q2
$386K Buy
+1,200
New +$390K ﹤0.01% 1978
2023
Q3
Sell
-192,000
Closed -$58.3M 2469
2023
Q2
$58.3M Buy
192,000
+191,100
+21,233% +$53.1M 0.15% 154
2023
Q1
$237K Buy
+900
New +$229K ﹤0.01% 2221
2022
Q1
Sell
-95,900
Closed -$24.6M 2798
2021
Q4
$24.6M Buy
95,900
+43,700
+84% +$10.7M 0.06% 266
2021
Q3
$12.7M Buy
+52,200
New +$12.8M 0.03% 446
2021
Q1
Sell
-279,200
Closed -$45.9M 2624
2020
Q4
$45.9M Sell
279,200
-146,300
-34% -$21.4M 0.12% 181
2020
Q3
$53.1M Sell
425,500
-391,936
-48% -$48.5M 0.15% 144
2020
Q2
$79.3M Buy
817,436
+260,500
+47% +$27.1M 0.23% 93
2020
Q1
$50M Buy
556,936
+129,500
+30% +$16.8M 0.19% 121
2019
Q4
$63.2M Buy
427,436
+279,644
+189% +$37.6M 0.15% 164
2019
Q3
$17.8M Sell
147,792
-165,500
-53% -$21.4M 0.04% 397
2019
Q2
$42.3M Sell
313,292
-629,300
-67% -$79.6M 0.11% 238
2019
Q1
$123M Sell
942,592
-66,800
-7% -$8.97M 0.31% 72
2018
Q4
$126M Buy
1,009,392
+331,885
+49% +$44.5M 0.34% 70
2018
Q3
$94.3M Buy
677,507
+622,400
+1,129% +$77.5M 0.23% 122
2018
Q2
$5.65M Sell
55,107
-36,400
-40% -$3.68M 0.02% 808
2018
Q1
$8.88M Sell
91,507
-115,300
-56% -$11.2M 0.02% 631
2017
Q4
$18.2M Sell
206,807
-39,000
-16% -$3.13M 0.05% 428
2017
Q3
$19.6M Sell
245,807
-93,260
-28% -$7.5M 0.06% 369
2017
Q2
$29.6M Sell
339,067
-802,740
-70% -$67.9M 0.1% 256
2017
Q1
$102M Buy
1,141,807
+56,252
+5% +$4.69M 0.33% 66
2016
Q4
$80.4M Buy
1,085,555
+407,025
+60% +$30.5M 0.31% 81
2016
Q3
$51.3M Sell
678,530
-551,103
-45% -$42.2M 0.22% 115
2016
Q2
$94.7M Sell
1,229,633
-4,800
-0.4% -$379K 0.48% 47
2016
Q1
$96.3M Sell
1,234,433
-172,469
-12% -$12M 0.54% 39
2015
Q4
$95.1M Buy
1,406,902
+657,364
+88% +$45.9M 0.57% 44
2015
Q3
$58M Sell
749,538
-441,626
-37% -$39.1M 0.37% 70
2015
Q2
$108M Buy
1,191,164
+285,331
+31% +$22.9M 0.8% 9
2015
Q1
$68.1M Sell
905,833
-416,298
-31% -$29.9M 0.5% 37
2014
Q4
$97M Sell
1,322,131
-474,800
-26% -$33.4M 0.75% 16
2014
Q3
$127M Sell
1,796,931
-24,300
-1% -$1.61M 0.95% 6
2014
Q2
$103M Sell
1,821,231
-242,200
-12% -$12.8M 0.8% 6
2014
Q1
$108M Sell
2,063,431
-169,700
-8% -$8.44M 0.99% 2
2013
Q4
$107M Sell
2,233,131
-211,700
-9% -$9.78M 1.03% 2
2013
Q3
$105M Sell
2,444,831
-75,687
-3% -$2.96M 1.25% 3
2013
Q2
$90.9M Buy
+2,520,518
New +$97.5M 1.3% 5

Other funds holding HCA

Two Sigma Advisers's HCA Position: Q1 2026 in Review

Two Sigma Advisers sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 4,660 shares — an estimated $2.18M sold.

Two Sigma Advisers first reported a position in HCA in Q2 2013 and held it in 38 quarters. The position peaked at $127M in Q3 2014. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Two Sigma Advisers reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 4,660 HCA Healthcare shares in Q1 2026, an estimated $2.18M.
  • Two Sigma Advisers first reported a position in HCA Healthcare in Q2 2013 and held it in 38 quarters.
  • Two Sigma Advisers's HCA Healthcare position peaked at $127M in Q3 2014.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.